Nature medicine

• 

  Año 2004, Número 2

  • Celebrating our tenth year

    págs. 107-108

    

  • Trading scientific freedom

    pág. 107

    

  • US pressures publishers to honor trade embargoes

    pág. 109

    

  • Animal research stance spells knight-mare for Blakemore

    pág. 109

    

  • Iraq's public health infrastructure a casualty of war

    pág. 110

    

  • Soldiers battle `Baghdad boil'

    pág. 110

    

  • World agencies try to stem flood of fake drugs

    pág. 111

    

  • For HIV vaccine trials, size does matter

    pág. 111

    

  • In world of epidemics, WHO's in control

    pág. 112

    

  • US soldiers refuse to fall in line with anthrax vaccination scheme

    pág. 112

    

  • Specificity of mechanisms for plaque removal after Abeta immunotherapy for Alzheimer disease

    págs. 117-118

    

  • International cooperation on xenotransplantation

    pág. 119

    

  • The `apparent' color of money

    pág. 120

    

  • The Greatest Experiment Ever Performed on Women: Exploding the Estrogen Myth By Barbara Seaman

    C. D. Toran-Allerand

    pág. 121

    

  • The Oxytocin Factor By Kerstin Uvnas Moberg

    C. A. Pedersen

    pág. 122

    

  • Sweet relief for Huntington disease

    M. Katsuno, H. Adachi

    pág. 123

    

  • Lipid unites disparate syndromes of sepsis

    C. J. Czura, H. Wang, K. J. Tracey

    págs. 124-125

    

  • Inflamed about obesity

    M. Lehrke, Mitchell A. Lazar

    pág. 126

    

  • EMSY, a BRCA-2 partner in crime

    D. M. Livingston

    págs. 127-128

    

  • Cities spawn epidemic dengue viruses

    D. J. Gubler

    pág. 129

    

  • Ceramide lances the lungs

    P. J. Barnes

    pág. 130

    

  • Gonorphoeae glue

    Charlotte Schubert

    pág. 131

    

  • RESEARCH NOTES

    pág. 132

    

  • HISTORICAL NEWS AND VIEWS: gp41: HIV's shy protein

    M. B. Zwick, E. O. Saphire

    págs. 133-134

    

  • Genetic, cellular and immune approaches to disease therapy: past and future

    G. J. Nabel

    págs. 135-142

    

  • Differentiating the pathologies of cerebral malaria by postmortem parasite counts

    T. E. Taylor

    págs. 143-144

    

  • Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

    C. G. Willett

    págs. 145-147

    

  • Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease

    M. Tanaka, Y. Machida

    págs. 148-154

    

  • PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide

    R. Goggel, S. Winoto-Morbach

    págs. 155-160

    

  • Therapeutic effects of lysophosphatidylcholine in experimental sepsis

    J.-J. Yan, J.-S. Jung

    págs. 161-167